Similarly, in pancreatic cancer, inhibition of TGF-β activation of pancreatic stellate cells by the peptide hormone relaxin-2 can decrease tumor growth and potentiate the effect of the chemotherapeutic drug gemcitabine [128]. This evidence concerns the gene TGFB1 and neoplasm.